Optimizing Dermatology Peer-to-Peer Scheduling with Klivira

Klivira streamlines dermatology peer-to-peer scheduling, transforming a resource-intensive process into an efficient, automated workflow that accelerates access to critical treatments.

For dermatology practices managing high volumes of prior authorizations for biologics and specialty procedures, denials often necessitate peer-to-peer (P2P) reviews. Manually coordinating these critical calls consumes significant staff and clinician time, leading to delays in patient care and increased administrative burden. Klivira's automation platform is designed to mitigate these challenges.

The Challenge of Peer-to-Peer Reviews in Dermatology

Dermatology prior authorizations frequently involve high-cost biologics for conditions like psoriasis, psoriatic arthritis, atopic dermatitis, and hidradenitis suppurativa, as well as complex procedures like Mohs micrographic surgery. Denials often stem from step therapy requirements, biosimilar substitution directives, or mismatches with appropriate use criteria. Navigating these denials through P2P reviews can be a significant bottleneck for dermatology practices, demanding precise documentation and clinician availability.

Common Dermatology PA Denials Requiring P2P Intervention

Failure to document step therapy for psoriasis biologics (e.g., prior topical, phototherapy, or conventional systemic trials).
Payer mandates for biosimilar substitution over prescribed TNF inhibitors.
Mohs surgery indications not aligning with payer-specific Appropriate Use Criteria (AUC) for site or tumor type.
Insufficient documentation of disease severity (e.g., missing PASI, EASI, or BSA scores for biologics).
Gaps in pre-biologic screening documentation (e.g., TB, hepatitis).
Challenges to off-label indications for advanced skin cancer treatments.

Klivira's Automated Peer-to-Peer Scheduling Workflow for Dermatology

Klivira's platform automates the entire peer-to-peer scheduling process, from denial triage to outcome capture, specifically addressing the high-volume and documentation-intensive nature of dermatology PA. This reduces the administrative load on PA coordinators and minimizes disruption to clinician schedules, ensuring timely P2P calls for critical biologics and procedures.

Key Features of Klivira's P2P Automation for Dermatology

**Smart Denial Triage**: Auto-detection of P2P-eligible denials based on specific dermatology PA reasons (e.g., clinical necessity, step therapy).
**Integrated Calendar Scheduling**: Seamlessly reconciles payer medical director availability with the ordering dermatologist's calendar via FHIR Appointment resources or configured integrations (e.g., Outlook, Google Calendar).
**Automated Pre-Call Packet Assembly**: Gathers all relevant clinical documentation, including AAD guideline conformance, PASI/BSA/EASI scores, prior-line therapy history, and lab/imaging results, delivering a structured packet to the clinician.
**Automated Reminders**: Delivers timely reminders to dermatologists and PA coordinators with case context and pre-call documentation attached.
**Structured Outcome Capture**: Enables clinicians to record P2P call outcomes via a structured form, with automated write-back to the EMR as FHIR DocumentReference and Communication resources.
**P2P Pattern Analytics**: Provides insights into P2P success rates by payer, denial reason, and specific dermatology drug/procedure, informing upstream PA submission improvements.

EMR and Payer Touchpoints in Dermatology P2P Automation

Effective dermatology peer-to-peer scheduling relies on robust integration with existing EMR systems and payer portals. Klivira leverages FHIR standards for clinician calendar integration and documentation retrieval, ensuring that all necessary clinical context—from patient demographics to detailed treatment histories and guideline adherence (e.g., AAD Clinical Guidelines)—is readily available. Our platform interacts with payer portals and communication channels to discover P2P availability windows and facilitate communication, streamlining the historically manual three-way scheduling process.

Driving Efficiency and Patient Access in Dermatology

By automating dermatology peer-to-peer scheduling, Klivira significantly reduces the time and effort spent on administrative tasks, allowing PA coordinators to focus on complex cases and clinicians to dedicate more time to patient care. This acceleration in the P2P process minimizes treatment delays for patients requiring biologics or Mohs surgery, improving patient outcomes and enhancing practice efficiency. The data-driven insights from P2P outcomes also help dermatology practices refine their initial PA submissions, reducing future denial rates.

Frequently asked questions

Which specific dermatology PA denials can Klivira's P2P automation address?

Klivira's P2P automation is particularly effective for denials related to clinical necessity, step therapy, biosimilar requirements, and appropriate use criteria for biologics (e.g., Dupixent, Cosentyx, Tremfya, Skyrizi) and Mohs surgery. It helps ensure that the dermatologist has all necessary documentation, such as PASI/BSA/EASI scores and prior treatment history, readily available for the call.

How does Klivira integrate with our dermatologists' calendars for P2P scheduling?

Klivira integrates with your EMR via FHIR Appointment resources where supported, or directly with common calendar systems like Outlook and Google Calendar. This allows the system to identify available slots in the dermatologist's schedule automatically, proposing optimal times for P2P calls without manual coordination.

What kind of documentation does Klivira assemble for dermatology P2P calls?

Klivira automatically compiles a comprehensive pre-call packet that includes relevant clinical notes, lab results, imaging reports, prior-line therapy history, and specific documentation for dermatology PA like PASI, BSA, or EASI scores, and adherence to AAD Clinical Guidelines or Mohs AUC. This packet is delivered to the clinician before the call.

Can Klivira help reduce the overall volume of P2P requests in dermatology?

While Klivira cannot eliminate all P2P requests, its P2P pattern analytics feature helps. By analyzing successful P2P outcomes based on denial reason, payer, and clinician, it provides insights that can inform and improve your initial PA submission strategies, potentially leading to fewer denials that require P2P in the future.

Does Klivira's P2P automation manage periodic re-authorizations for chronic dermatology biologics?

Yes, Klivira's platform supports the workflow for periodic re-authorization of chronic biologic treatments. Should a re-authorization receive a P2P-eligible denial, it will be routed through the automated P2P scheduling process, ensuring continuity of care for patients on long-term therapies like those for psoriasis or atopic dermatitis.